Unique ID issued by UMIN | UMIN000052346 |
---|---|
Receipt number | R000059761 |
Scientific Title | Prospective Evaluation of Oocyte Yield After Granulocyte Colony-Stimulating Factor Priming in Women with Severe Diminished Ovarian Reserve: A Non-Randomized Clinical Investigation |
Date of disclosure of the study information | 2023/09/28 |
Last modified on | 2025/01/20 16:40:25 |
A Prospective, Non-Randomized Clinical Study on the Efficacy of Oocyte Retrieval Following G-CSF Priming in Cases with Severe Ovarian Reserve Insufficiency
G-ORES (G-CSF Oocyte Retrieval Efficacy Study)
Prospective Evaluation of Oocyte Yield After Granulocyte Colony-Stimulating Factor Priming in Women with Severe Diminished Ovarian Reserve: A Non-Randomized Clinical Investigation
PEORY-G (Prospective Evaluation of Oocyte Retrieval Yield with G-CSF)
Japan |
Infertility
Obstetrics and Gynecology |
Others
NO
To elucidate the impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the success rate of oocyte retrieval in women diagnosed with Diminished Ovarian Reserve (DOR).
Safety
Oocyte retrieval success rate in the subsequent cycle following G-CSF priming.
Cumulative oocyte retrieval success rate up to six months post-G-CSF treatment.
Cumulative pregnancy rate up to six months post-G-CSF treatment.
Follicular growth metrics observed after G-CSF priming.
Changes in Anti-Mullerian Hormone (AMH) levels post-G-CSF treatment.
Time duration from G-CSF injection to successful oocyte retrieval within six months post-treatment.
Time duration from G-CSF injection to clinical pregnancy confirmation within six months post-treatment.
Incidence of adverse events observed post-G-CSF administration.
Interventional
Parallel
Non-randomized
Open -no one is blinded
No treatment
2
Treatment
Medicine |
Initiate the oocyte retrieval cycle following subcutaneous administration of 300ug of G-CSF (Filgrastim BS Injection 300ug Syringe F) during the early luteal phase.
Initiate the oocyte retrieval cycle without the use of G-CSF.
20 | years-old | <= |
50 | years-old | > |
Female
Participants must be aged 20 years or older.
Participants must have a history of at least one cancelled oocyte retrieval cycle due to lack of follicular development.
Participants must be diagnosed with Diminished Ovarian Reserve (DOR) by a qualified physician.
Participants must have no prior history of pregnancy.
Participants must not have any other underlying medical conditions.
Participants must provide written informed consent, acknowledging an understanding of the study's objectives and procedures.
Participants experiencing mental instability or other factors that would make participation in the study difficult are excluded.
220
1st name | Shinnosuke |
Middle name | |
Last name | Komiya |
HORAC Grand Front Osaka Clinic
Gynecology
530-0011
Grand Frront Osaka Tower B 15F, 3-1, Ofuka-cho, Kita-ku, Osaka city, Osaka, Japan
0636778824
komiya0703@gmail.com
1st name | Shinnosuke |
Middle name | |
Last name | Komiya |
HORAC Grand Front Osaka Clinic
Gynecology
530-0011
Grand Frront Osaka Tower B 15F, 3-1, Ofuka-cho, Kita-ku, Osaka city, Osaka, Japan
0636778824
komiya0703@gmail.com
HORAC Grand Front Osaka Clinic
Self-funding
Self funding
HORAC Grand Front Osaka Clinic
Grand Frront Osaka Tower B 15F, 3-1, Ofuka-cho, Kita-ku, Osaka city, Osaka, Japan
0636778824
komiya0703@gmail.com
NO
2023 | Year | 09 | Month | 28 | Day |
Unpublished
Enrolling by invitation
2023 | Year | 09 | Month | 20 | Day |
2024 | Year | 01 | Month | 01 | Day |
2024 | Year | 01 | Month | 01 | Day |
2026 | Year | 12 | Month | 31 | Day |
2023 | Year | 09 | Month | 28 | Day |
2025 | Year | 01 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059761